Researching Modifiable and Non-Modifiable Risk Factors Linked to Cognitive Resilience in Alzheimer’s Disease
What do we do?
Our lab focuses on clarifying how alterations in the brain and other biomolecules (such as cerebrospinal fluid β-amyloid) place some cognitively-normal individuals on a pernicious trajectory that culminates in Alzheimer’s dementia. In this context, we are particularly interested in discovering new knowledge concerning the modulation of the link between brain changes and cognitive decline by both modifiable (e.g., cognitively-stimulating activities, physical exercise) and non-modifiable (e.g., genetic vulnerability) factors. Overlaid on this research agenda are investigations of health accessibility, and how such accessibility exacerbates or ameliorates the impact of biomarkers on clinical phenotypes.
We use many techniques in our research, including but not limited to:
This is an accordion element with a series of buttons that open and close related content panels.
MRI and PET Imaging


Cerebrospinal Fluid Collection

Maximal Exercise Testing


Blood-based Biomarkers

Physical Activity Monitoring

Cognitive Testing

We are a part of the larger Wisconsin Alzheimer’s Disease Research Program, which includes both the Wisconsin Alzheimer’s Disease Research Center and the Wisconsin Alzheimer’s Institute.
Our offices are located on UW Madison’s campus within the UW Hospital and WARF. The majority of our research is conducted at the UW Hospital, the Waisman Center, the Wisconsin Institute for Medical Research, and the YMCA.
News Highlights

Ozioma Okonkwo Invited as Guest Speaker at IADRC Martin Family Alzheimer’s Disease Caregiver Symposium
Ozioma Okonkwo was invited to be the guest speaker at the Indiana Alzheimer Disease Research Center’s 20th Annual Martin Family Alzheimer’s Disease Caregiver Symposium in Indianapolis, Indiana on September 4. His talk was titled Pushing …
September 10, 2026
Ozioma Okonkwo Invited to Join The DOM Belonging and Well-Being Committee
Ozioma Okonkwo has been invited to join the DOM Belonging and Well-Being Committee! This committee advises on how to intentionally create a culture of inclusion, belonging, and well-being, and how to share information that supports …
September 9, 2026
Ira Frahmand Invited to Speak at KLOTHO Conference and Scientific Seminar
Ira Frahmand has been invited to speak at the Second Annual KLOTHO Conference and Scientific Seminar in Miami, Florida from September 18-19. Her talk is titled “KLOTHO KL-VS and aging phenotypes”.
September 9, 2026
Ozioma Okonkwo Appointed to North Texas ADRC External Advisory Committee
Ozioma Okonkwo has been invited to serve on the External Advisory Committee for the North Texas Alzheimer’s Disease Research Center (ADRC). The North Texas ADRC was established earlier this year, and Ozioma will have the …
September 3, 2026- More News





